Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1905 clinical trials
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

This study will compare the effectiveness of osimertinib alone with the combination of osimertinib and chemotherapy (carboplatin and pemetrexed) in people with metastatic lung cancer that has a

liver metastasis
osimertinib
carboplatin
neutrophil count
gilbert's syndrome
  • 0 views
  • 14 Apr, 2021
  • 11 locations
Sublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung Cancer

inferior to lobectomy for cT1N0M0 non-small-cell lung cancer or not.

lung carcinoma
  • 0 views
  • 22 Jan, 2021
  • 1 location
A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer

This study is about a medicine called TAK-788, also known as mobocertinib, given to adults with non-small cell lung cancer. The main aims of this study are to check if there are any side

epidermal growth factor
carboplatin
lung carcinoma
growth factor
metastasis
  • 0 views
  • 31 May, 2021
  • 98 locations
A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer Patients

with locally advanced, unresectable, non-small cell lung cancer (Stage III), who have not progressed following definitive, platinum-based, chemoradiation therapy.

durvalumab
chemoradiotherapy
lung carcinoma
  • 284 views
  • 13 Jun, 2021
  • 147 locations
KN046 in Subjects With Advanced Squamous Non-small Cell Lung Cancer

This study is a randomized, double-blind, multicenter, phase III clinical study to compare the clinical efficacy and safety of KN046 plus paclitaxel and carboplatin versus placebo plus paclitaxel and carboplatin in subjects with advanced squamous NSCLC who have not previously received systemic treatment.

  • 0 views
  • 26 Jan, 2021
  • 1 location
Double Immune Checkpoint Inhibitors in PD-L1-positive Stage IV Non-small Lung CancEr

Non Small Cell lung cancer (NSCLC) remains the first cause of death by cancer in the World. For the patients presenting a NSCLC stage IV, the median of survival is about 15 months today. The

liver metastasis
nivolumab
ipilimumab
pd-l1
tumor cells
  • 22 views
  • 25 Jan, 2021
  • 46 locations
Durvalumab vs Placebo With Stereotactic Body Radiation Therapy in Early Stage Unresected Non-small Cell Lung Cancer Patients

This is a Phase III, randomized, placebo-controlled, double-blind, multi-center study assessing the efficacy and safety of durvalumab with SoC SBRT versus placebo with SoC SBRT in patients with unresected clinical Stage I/II lymph node-negative (T1 to T3N0M0) NSCLC.

durvalumab
stereotactic body radiation therapy
lung carcinoma
  • 68 views
  • 28 Apr, 2021
  • 227 locations
Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy

The purpose of this study is to improve early detection of treatable relapse of lung cancer and thereby improve survival and quality of life for the patients. The investigators will perform a

ct scan
liquid biopsy
cancer chemotherapy
lung carcinoma
adjuvant chemotherapy
  • 0 views
  • 26 Jan, 2021
  • 3 locations
Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer

-small cell lung cancer compared to the combination of paclitaxel and carboplatin alone

stage iv non-small cell lung cancer
carboplatin
paclitaxel
  • 10 views
  • 07 Nov, 2020
  • 1 location
A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

) mutation (Exon 19 deletions [Exon 19del] or Exon 21 L858R substitution) positive, locally advanced or metastatic non-small cell lung cancer (NSCLC).

measurable disease
osimertinib
solid tumour
epidermal growth factor
cancer treatment
  • 27 views
  • 02 Jun, 2021
  • 308 locations